Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03887091 · ClinicalTrials.gov registry record · NA
Personal Web Page In Clinical Trial Participant Education
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT03887091 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 99 participants.
The verdict
NCT03887091, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
This research study is evaluating the effectiveness of video and web-based communication in clinical research compared to standard practices.
Interventions
- OTHER Postwire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2014-07-21 |
| Est. Completion | 2019-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03887091
The ClinicalTrials.gov registry entry for NCT03887091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Postwire is the first listed.
NCT03887091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03887091 about?
NCT03887091 is a clinical study titled "Personal Web Page In Clinical Trial Participant Education". This research study is evaluating the effectiveness of video and web-based communication in clinical research compared to standard practices.
What is the current status of trial NCT03887091?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2014-07-21. Estimated completion is 2019-05.
What interventions are being tested in trial NCT03887091?
The interventions under investigation include: Postwire (OTHER).
Who is sponsoring clinical trial NCT03887091?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.